ProShares Ultra Profile

64.04
USD 0.18  0.28%
43%
55%

ProShares Ultra Summary

ProShares Ultra Nasdaq Biotechnology [BIB] is traded in USA and was established on August 15, 2018. The fund is classified under Sector category within ProShares family. ProShares Ultra Nasdaq Biotechnology currently have 443.14 M in assets under management (AUM). , while the total return for the last 3 years was -14.15%.
Check ProShares Ultra Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Top Etf Constituents

Target Price Odds Analysis

Odds Below 64.04HorizonTargetOdds Above 64.04
18.84%30 days 64.04 80.80%
Based on normal probability distribution, the odds of ProShares Ultra to move above current price in 30 days from now is about 80.8% (This ProShares Ultra Nasdaq Biotechnology probability density function shows the probability of ProShares Ultra Etf to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Simplex Trading LlcCall Options7.1 K26.1 M
Chase Investment Counsel CorpFund Units46.4 K2.7 M
Summit Securities Group LlcPut Options200719 K
View ProShares Ultra Diagnostics

ProShares Ultra Nasdaq Risk Profiles

ProShares Ultra Nasdaq Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. ProShares Ultra Nasdaq Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ProShares Ultra price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

ProShares Ultra Against Markets

Current Ratings

ProShares Ultra 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
32 
Equity ratings for ProShares Ultra Nasdaq Biotechnology are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks daily investment results that correspond to two times the daily performance of the Nasdaq Biotechnology Index. ProShares Ultra is traded on NASDAQ General Markets in USA. more
NameProShares Ultra Nasdaq Biotechnology
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerProShares
ExchangeNASDAQ General Markets
Etf FamilyProShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone866 776 5125
CurrencyUSD - US Dollar
IssuerProShares
DescriptionProShares Ultra Nasdaq Biotechnology
Inception Date2010-04-07
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management443.14 Million
Average Trading Valume77,066
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year EndMay 31
ExchangeThe NASDAQ Stock Market LLC
Market MakerVirtu Financial
Total Expense1.04
Management Fee0.75

Did you try this?

Run Fundamentals Comparison Now
   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Fundamentals Comparison
Check also Trending Equities. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.